GPX4 and necrotizing enterocolitis: In line with the in vitro results, miR-155–5p inhibition substantially elevated the expression of SLC7A11 and GPX4 while reducing COX-2 and ACSL4 levels in the intestinal tissues of NEC rats (Fig. 8A, B, and 8C).